Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
07.08. | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT UPDATE REGARDING CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE ... | 2 | HKEx | ||
05.08. | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT WITHDRAWAL OF LISTING OF H SHARES AND EXPECTED TIMELINE FOR THE WITHDRAWAL OF LISTING AND THE IMPLEMENTATION ... | 1 | HKEx | ||
31.07. | HEC CJ PHARM (01558): SPECIAL DIVIDEND (UPDATED) | - | HKEx | ||
31.07. | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT IN RESPECT OF THE SPECIAL DIVIDEND | - | HKEx | ||
23.07. | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT RESULTS OF EXERCISE OF RIGHT OF DISSENTING SHAREHOLDERS | - | HKEx | ||
22.07. | HEC CJ PHARM (01558): DISCLOSURE OF DEALINGS UNDER RULE 22 OF THE TAKEOVERS CODE | 3 | HKEx | ||
YICHANG HEC CHANGJIANG PHARMACEUTICAL Aktie jetzt für 0€ handeln | |||||
21.07. | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT (1) POLL RESULTS OF THE EGM AND THE H SHAREHOLDERS' CLASS MEETING HELD ON MONDAY, 21 JULY 2025 RELATING TO THE ... | 1 | HKEx | ||
07.07. | HEC CJ PHARM (01558): DISCLOSURE OF DEALINGS UNDER RULE 22 OF THE TAKEOVERS CODE | 1 | HKEx | ||
30.06. | HEC CJ PHARM (01558): SPECIAL DIVIDEND (UPDATED) | - | HKEx | ||
27.06. | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT PROPOSED CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE PHARMA ... | - | HKEx | ||
26.06. | HEC CJ PHARM (01558): DISCLOSURE OF DEALINGS UNDER RULE 22 OF THE TAKEOVERS CODE | - | HKEx | ||
18.06. | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT PROPOSED PRE-CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE PHARMA ... | - | HKEx | ||
18.06. | HEC CJ PHARM (01558): DISCLOSURE OF DEALINGS UNDER RULE 22 OF THE TAKEOVERS CODE | - | HKEx | ||
10.06. | HEC CJ PHARM (01558): DISCLOSURE OF DEALINGS UNDER RULE 22 OF THE TAKEOVERS CODE | 3 | HKEx | ||
09.06. | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT MONTHLY UPDATE IN RELATION TO THE PROPOSED PRE-CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL ... | 1 | HKEx | ||
29.05. | HEC CJ PHARM (01558): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 29 MAY 2025 | - | HKEx | ||
28.05. | HEC CJ PHARM (01558): DISCLOSURE OF DEALINGS UNDER RULE 22 OF THE TAKEOVERS CODE | 1 | HKEx | ||
09.05. | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT MONTHLY UPDATE IN RELATION TO THE PROPOSED PRE-CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL ... | - | HKEx | ||
02.05. | HEC CJ PHARM (01558): DISCLOSURE OF DEALINGS UNDER RULE 22 OF THE TAKEOVERS CODE | 2 | HKEx | ||
28.04. | HEC CJ PHARM (01558): FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, 29 MAY 2025 (OR ANY ADJOURNMENT THEREOF) | - | HKEx |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SANOFI | 86,40 | -0,21 % | Verhaltene Kauflaune bei Sanofi SA-Aktie (87,18 €) | Am Aktienmarkt ist der Anteilsschein von Sanofi SA zur Stunde unauffällig. Das Papier kostete zuletzt 87,18 Euro. Kaum verändert im Vergleich zu der letzten Notierung des vorigen Handelstages zeigt... ► Artikel lesen | |
GSK | 17,050 | +0,38 % | GSK-Erfolg stärkt Veeva: Raymond James bekräftigt "Outperform"-Rating | ||
ABBVIE | 178,20 | -0,45 % | AbbVie To Acquire Gilgamesh's Lead Investigational Candidate, Bretisilocin, For Up To $1.2 Bln | WASHINGTON (dpa-AFX) - AbbVie, Inc. (ABBV) and Gilgamesh Pharmaceuticals Inc. announced Monday a definitive agreement under which AbbVie will acquire Gilgamesh's lead investigational candidate... ► Artikel lesen | |
ELI LILLY | 631,50 | -0,13 % | KI-Revolution macht BioTech zur Goldgrube! BioNTech, Eli Lilly, NetraMark Holdings und Pfizer wissen wie! | Anzeige / WerbungKünstliche Intelligenz (KI) gewinnt in der Medikamentenforschung immer mehr an Bedeutung und revolutioniert die Entwicklung neuer Wirkstoffe.
Durch maschinelles Lernen und neuronale... ► Artikel lesen | |
TEVA | 15,350 | -1,60 % | Piper Sandler Reiterates a Buy Rating on Teva Pharmaceutical Industries (TEVA) | ||
BIOTEST | 30,200 | +0,67 % | EQS-News: Biotest AG: Die Biotest AG erhält ein Einberufungsverlangen von Grifols S.A. für eine außerordentliche Hauptversammlung | EQS-News: Biotest AG
/ Schlagwort(e): Rechtssache
Die Biotest AG erhält ein Einberufungsverlangen von Grifols S.A. für eine außerordentliche Hauptversammlung
04.08.2025... ► Artikel lesen | |
SINOPHARM | 2,150 | +0,37 % | BofAS Adds SINOPHARM TP to $23, Reaffirms Rating at Buy | ||
CSPC PHARMA | 1,152 | -1,33 % | HSI Down 304 pts; HSTI Down 42 pts; CSPC PHARMA Down over 4%; ZIJIN MINING, NAGACORP, HUABAO INTL, CHINAGOLDINTL, CTIHK Hit New Highs; Market Turnover Rises | ||
SANTHERA PHARMACEUTICALS | 14,840 | +1,23 % | Santhera signs deal with Uniphar for GCC distribution of Agamree | ||
WUXI BIOLOGICS | 3,636 | +1,73 % | CLSA Lifts WUXI BIO's TP to HKD42.6, Anticipates Growth to Resume Acceleration | ||
OPKO HEALTH | 1,187 | -0,93 % | OPKO Health, Inc.: OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting | MIAMI and JERUSALEM, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX) ("Entera") today announced that new pharmacologic and pharmacokinetic in vivo... ► Artikel lesen | |
UNITED THERAPEUTICS | 262,80 | -1,05 % | Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics | New litigation filed against Liquidia in U.S. District Court for the Middle District of North Carolina alleges infringement of UTHR's '782 patent and seeks to enjoin Liquidia from commercializing... ► Artikel lesen | |
SHANGHAI FOSUN PHARMACEUTICAL | 2,298 | -1,46 % | Fosun Pharma Announces 2025 Interim Results | Enhancing Innovation Efficiency and Steadily Expanding Globally
SHANGHAI, Aug. 26, 2025 /PRNewswire/ -- On August 26, 2025, Shanghai Fosun Pharmaceutical (Group)... ► Artikel lesen | |
GEDEON RICHTER | 26,360 | +0,15 % | Gedeon Richter Plc.: Long-term Commitment to Treating Endometriosis and Improving Women's Quality of Life - Gedeon Richter at the World Congress on Endometriosis | SYDNEY, May 28, 2025 /PRNewswire/ --
Gedeon Richter had a strong presence at the World Congress of Endometriosis held this year in Sydney, Australia between 21-24 May 2025. As a Platinum... ► Artikel lesen | |
DR REDDYS | 12,100 | -1,63 % | DR REDDYS LABORATORIES LTD - 6-K, Report of foreign issuer |